Literature DB >> 8442428

Micro-ecology of the nasopharyngeal bacterial flora in otitis-prone and non-otitis-prone children.

J M Bernstein1, H F Faden, D M Dryja, J Wactawski-Wende.   

Abstract

The quantitative bacteriology of the adenoid was studied in otitis-prone and non-otitis-prone children. alpha-hemolytic Streptococci (Viridans Streptococci) appeared to be predominant normal flora in the healthy nasopharynx. There was a decrease in alpha-hemolytic Streptococci in the otitis-prone child compared to the non-otitis-prone child. Concomitantly, there appears to be an increase in both nontypable Haemophilus influenzae (NTHI) and S. pneumoniae in the nasopharyngeal flora in the otitis-prone child. The mechanisms responsible for this alteration of the micro-ecology of bacteria of the nasopharynx may be related, in part, to factors that alter mucociliary function. These factors could be viral infection, allergy, local and systemic immunological deficiency and the indiscriminate use of antibiotics. An understanding of the relationship between the normal flora and the potential pathogens may be important in the understanding of both the pathogenesis of otitis media (OM) and possibly the treatment of this disease entity.

Entities:  

Mesh:

Year:  1993        PMID: 8442428     DOI: 10.3109/00016489309135772

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  18 in total

1.  Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation.

Authors:  John T Wren; Lance K Blevins; Bing Pang; Lauren B King; Antonia C Perez; Kyle A Murrah; Jennifer L Reimche; Martha A Alexander-Miller; W Edward Swords
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Is Adenoidectomy Preventable?

Authors:  Giorgio Ciprandi; Ignazio La Mantia; Attilio Varricchio
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-06-01

3.  Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial.

Authors:  K Roos; E G Håkansson; S Holm
Journal:  BMJ       Date:  2001-01-27

4.  Passive smoking and nasopharyngeal colonization by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in daycare children.

Authors:  Mehdi Bakhshaee; Hamid Reza Naderi; Kiarash Ghazvini; Kambiz Sotoudeh; Amin Amali; Sara Jafari Ashtiani
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-28       Impact factor: 2.503

5.  Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.

Authors:  Ravinder Kaur; Matthew Morris; Michael E Pichichero
Journal:  Pediatrics       Date:  2017-08-07       Impact factor: 7.124

6.  Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection.

Authors:  L O Bakaletz; B J Kennedy; L A Novotny; G Duquesne; J Cohen; Y Lobet
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

7.  The Use of Probiotics in Head and Neck Infections.

Authors:  Kristian Roos; Stig Holm
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

8.  Streptococcus salivarius 24SMB administered by nasal spray for the prevention of acute otitis media in otitis-prone children.

Authors:  P Marchisio; M Santagati; M Scillato; E Baggi; M Fattizzo; C Rosazza; S Stefani; S Esposito; N Principi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-18       Impact factor: 3.267

9.  Turnover of nonencapsulated Haemophilus influenzae in the nasopharynges of otitis-prone children.

Authors:  A Samuelson; A Freijd; J Jonasson; A A Lindberg
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

10.  Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidates.

Authors:  Laura A Novotny; Leanne D Adams; D Richard Kang; Gregory J Wiet; Xueya Cai; Sanjay Sethi; Timothy F Murphy; Lauren O Bakaletz
Journal:  Vaccine       Date:  2009-08-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.